GMXPX
Price
$25.25
Change
+$0.39 (+1.57%)
Updated
Nov 21 closing price
Net Assets
563.89M
VIVIX
Price
$72.32
Change
+$0.97 (+1.36%)
Updated
Nov 21 closing price
Net Assets
207.95B
Interact to see
Advertisement

GMXPX vs VIVIX

Header iconGMXPX vs VIVIX Comparison
Open Charts GMXPX vs VIVIXBanner chart's image
Goldman Sachs Large Cp Val Insghts P
Price$25.25
Change+$0.39 (+1.57%)
VolumeN/A
Net Assets563.89M
Vanguard Value Index I
Price$72.32
Change+$0.97 (+1.36%)
VolumeN/A
Net Assets207.95B
GMXPX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
GMXPX vs. VIVIX commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMXPX is a Hold and VIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 208B vs. GMXPX (564M). VIVIX pays higher dividends than GMXPX: VIVIX (2.10) vs GMXPX (1.09). GMXPX was incepted earlier than VIVIX: GMXPX (8 years) vs VIVIX (27 years). GMXPX (0.65) is less costly to investors than VIVIX (0.04). GMXPX is a more actively managed with annual turnover of: 206.00 vs. VIVIX (9.00). GMXPX has a lower initial minimum investment than VIVIX: GMXPX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 2.45 vs. GMXPX (-8.15). VIVIX return over 5 years is better than : 61.14 vs. GMXPX (25.41).
GMXPXVIVIXGMXPX / VIVIX
Total Expense Ratio0.550.041,375%
Annual Report Gross Expense Ratio0.650.041,625%
Fund Existence8 years27 years-
Gain YTD8.6178.141106%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets564M208B0%
Annual Yield % from dividends1.092.1052%
Returns for 1 year-8.152.45-333%
Returns for 3 years17.1427.0763%
Returns for 5 years25.4161.1442%
Returns for 10 yearsN/A120.40-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRDA10.160.99
+10.80%
Entrada Therapeutics
LILA8.230.27
+3.39%
Liberty Latin America Ltd
EDU51.650.47
+0.92%
New Oriental Education and Technology Group
DRDBU10.95N/A
N/A
Roman DBDR Acquisition Corp. II
MNY1.23-0.02
-1.36%
MoneyHero Limited